Dr. Luai Hasoun

Profiles:

Taibi Ben Hadda, Faisal A. Almalkib, Luai Z. Hasoun, Hind Lafridid, Ghizlan Maymoun, Hsaine Zgou, Aso Hameed Hasane, Joazaizulfazli Jamalis, Abdelkader Zarrouk, Ahmed Abu- Rayyan, Sumeer Ahmed, Ajmal R. Bhat (2026) Design of Novel Hybrid Thiourea–Phosphonate Derivatives as Potential Anti-TMV Agents: In Silico Evaluation and (S,O)-Pharmacophoric Site Identification Journal of Biochemical and Molecular Toxicology, Issue6, Volume40, 2026, e70904
Fayiz Adel Aldheisat, Heba A Khader, Luai Z. Hasoun, Zekrayat J.H. Medras, Muath Alsarafandi, Yazan Alsayed, Ahmad R. Alsayed. (2026) Pharmacist-oriented evaluation of inpatient management of primary hypertension using a problem-based care framework and exploratory predictive modeling Pharmacy Practice, 24(3):3685.
Luai Z. Hasoun, Heba A. Khader, Ahmad R. Alsayed, Mariam I Shaqfeh, Anas Samara, Malek A. Zihlif (2026) The effects of trade names on the misuse of some over-thecounter drugs Pharmacy Practice, 24(3):3413.
Bhavesh S. Hirani, Mohammad Murwih Alidmat, Luai Z. Hasoun, Sevak B Gurubaxani, Ahmad Sundookah, Sumeer Ahmed, Mohd Sajid Ali, Ajmal R. Bhat, Habtamu Abebe Agisho, Ana Maria Zbancioc & Hamad A. Al-Lohedan (2026) Green synthesis of tetrahydropyridine-3-carboxylate derivatives and evaluation of antimicrobial and antimalarial activities supported by molecular docking, POM studies, and drug-likeness analysis Scientific Reports, 16, Article number: 24000 (2026)